Diversity-oriented synthesis; a spectrum of approaches and results.
暂无分享,去创建一个
[1] Juan J Perez,et al. Managing molecular diversity. , 2005, Chemical Society reviews.
[2] E Uriarte,et al. Recent advances on the role of topological indices in drug discovery research. , 2001, Current medicinal chemistry.
[3] David R Spring,et al. Chemical genetics to chemical genomics: small molecules offer big insights. , 2005, Chemical Society reviews.
[4] D. Tejedor,et al. A substrate-based folding process incorporating chemodifferentiating ABB' three-component reactions of terminal alkynoates and 1,2-dicarbonyl compounds: a skeletal-diversity-oriented synthetic manifold. , 2007, Chemistry.
[5] Robert Häner,et al. Natural product-like libraries based on non-aromatic, polycyclic motifs. , 2005, Current opinion in chemical biology.
[6] Stuart L Schreiber,et al. Diversity-oriented synthesis of biaryl-containing medium rings using a one bead/one stock solution platform. , 2002, Journal of the American Chemical Society.
[7] Derek S. Tan,et al. Diversity-oriented synthesis: exploring the intersections between chemistry and biology , 2005, Nature chemical biology.
[8] C. Dobson. Chemical space and biology , 2004, Nature.
[9] D. Tejedor,et al. Chemo-differentiating ABB' multicomponent reactions. Privileged building blocks. , 2007, Chemical Society reviews.
[10] Stuart L Schreiber,et al. A synthesis strategy yielding skeletally diverse small molecules combinatorially. , 2004, Journal of the American Chemical Society.
[11] Miklos Feher,et al. Property Distributions: Differences between Drugs, Natural Products, and Molecules from Combinatorial Chemistry , 2003, J. Chem. Inf. Comput. Sci..
[12] Valler,et al. Diversity screening versus focussed screening in drug discovery. , 2000, Drug discovery today.
[13] John A. Tallarico,et al. Small-molecule diversity using a skeletal transformation strategy. , 2005, Organic letters.
[14] S. Schreiber. Chemical genetics resulting from a passion for synthetic organic chemistry. , 1998, Bioorganic & medicinal chemistry.
[15] Andreas Bender,et al. Anti-MRSA agent discovery using diversity-oriented synthesis. , 2008, Angewandte Chemie.
[16] John P. Overington,et al. How many drug targets are there? , 2006, Nature Reviews Drug Discovery.
[17] D. Spring,et al. Cell-cell communication in Gram-negative bacteria. , 2005, Molecular bioSystems.
[18] A. Hopkins,et al. The druggable genome , 2002, Nature Reviews Drug Discovery.
[19] P. Arya,et al. Natural product-like chemical space: search for chemical dissectors of macromolecular interactions. , 2005, Current opinion in chemical biology.
[20] Yvonne C. Martin,et al. Use of Structure-Activity Data To Compare Structure-Based Clustering Methods and Descriptors for Use in Compound Selection , 1996, J. Chem. Inf. Comput. Sci..
[21] R. Glen,et al. Molecular similarity: a key technique in molecular informatics. , 2004, Organic & biomolecular chemistry.
[22] T. Keller,et al. A practical view of 'druggability'. , 2006, Current opinion in chemical biology.
[23] Stuart L Schreiber,et al. Discovery of an inhibitor of a transcription factor using small molecule microarrays and diversity-oriented synthesis. , 2003, Journal of the American Chemical Society.
[24] K. S. Lam,et al. New aspects of natural products in drug discovery. , 2007, Trends in microbiology.
[25] A. Schuffenhauer,et al. Charting biologically relevant chemical space: a structural classification of natural products (SCONP). , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[26] T. Kirchhausen,et al. Synthesis of a 10,000-membered library of molecules resembling carpanone and discovery of vesicular traffic inhibitors. , 2006, Journal of the American Chemical Society.
[27] S. Schreiber,et al. Stereochemical control of skeletal diversity. , 2003, Organic letters.
[28] Suzanne Fergus,et al. Skeletal diversity construction via a branching synthetic strategy. , 2006, Chemical communications.
[29] Stuart L Schreiber,et al. Towards the optimal screening collection: a synthesis strategy. , 2008, Angewandte Chemie.
[30] Herbert Waldmann,et al. Protein structure similarity clustering (PSSC) and natural product structure as inspiration sources for drug development and chemical genomics. , 2005, Current opinion in chemical biology.
[31] Stuart L Schreiber,et al. Skeletal diversity via a folding pathway: synthesis of indole alkaloid-like skeletons. , 2005, Organic letters.
[32] F. Lombardo,et al. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings , 1997 .
[33] J. Porco,et al. An approach to skeletal diversity using functional group pairing of multifunctional scaffolds. , 2007, Organic letters.
[34] A. Bender,et al. Modeling Promiscuity Based on in vitro Safety Pharmacology Profiling Data , 2007, ChemMedChem.
[35] Stuart L. Schreiber,et al. The small-molecule approach to biology , 2003 .
[36] Peter Ertl,et al. Relationships between Molecular Complexity, Biological Activity, and Structural Diversity , 2006, J. Chem. Inf. Model..
[37] M. Butler. Natural products to drugs: natural product-derived compounds in clinical trials. , 2005, Natural product reports.
[38] L Xue,et al. Molecular descriptors in chemoinformatics, computational combinatorial chemistry, and virtual screening. , 2000, Combinatorial chemistry & high throughput screening.
[39] David R Spring,et al. Diversity-oriented synthesis; a challenge for synthetic chemists. , 2003, Organic & biomolecular chemistry.
[40] Cele Abad-Zapatero,et al. A sorcerer's apprentice and The Rule of Five: from rule-of-thumb to commandment and beyond. , 2007, Drug discovery today.
[41] Andrew R. Leach,et al. Molecular Complexity and Its Impact on the Probability of Finding Leads for Drug Discovery , 2001, J. Chem. Inf. Comput. Sci..
[42] R. Larock,et al. Diversity-oriented synthesis of 3-iodochromones and heteroatom analogues via ICl-induced cyclization. , 2006, The Journal of organic chemistry.
[43] Stuart L. Schreiber,et al. Dissecting glucose signalling with diversity-oriented synthesis and small-molecule microarrays , 2002, Nature.
[44] Stuart L Schreiber,et al. A planning strategy for diversity-oriented synthesis. , 2004, Angewandte Chemie.
[45] S. Schreiber,et al. Target-oriented and diversity-oriented organic synthesis in drug discovery. , 2000, Science.
[46] Eunha Kim,et al. Concise and diversity-oriented synthesis of novel scaffolds embedded with privileged benzopyran motif. , 2006, Chemical communications.
[47] Sara H Fitzgerald,et al. Survey of the diversity space coverage of reported combinatorial libraries. , 2007, Journal of combinatorial chemistry.
[48] Stuart L Schreiber,et al. Generating Diverse Skeletons of Small Molecules Combinatorially , 2003, Science.
[49] A. Bender,et al. Assessment of structural diversity in combinatorial synthesis. , 2005, Current opinion in chemical biology.
[50] Herbert Waldmann,et al. Discovery of protein phosphatase inhibitor classes by biology-oriented synthesis. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[51] Christopher T. Walsh,et al. Lessons from natural molecules , 2004, Nature.
[52] Stephen J Haggarty,et al. The principle of complementarity: chemical versus biological space. , 2005, Current opinion in chemical biology.
[53] Peter Willett,et al. Similarity Searching and Clustering of Chemical-Structure Databases Using Molecular Property Data , 1994, J. Chem. Inf. Comput. Sci..
[54] A. Hopkins,et al. Navigating chemical space for biology and medicine , 2004, Nature.
[55] Giovanni Muncipinto,et al. Short synthesis of skeletally and stereochemically diverse small molecules by coupling petasis condensation reactions to cyclization reactions. , 2006, Angewandte Chemie.
[56] S. Schreiber. PERSPECTIVE: THE SMALL-MOLECULE APPROACH TO BIOLOGYChemical genetics and diversity-oriented organic synthesis make possible the systematic exploration of biology , 2003 .
[57] Paul A Clemons,et al. Relationship of stereochemical and skeletal diversity of small molecules to cellular measurement space. , 2004, Journal of the American Chemical Society.